MS
Morgan Stanley
MS has the edge over OPRT overall, supported by lower modeled downside and stronger valuation.
OPRT
Oportun Financial Corporation
OPRT's outlook is improving, though it still trails on the overall score.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
OPRT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
OPRT's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like OPRT.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS has the edge over OPRT in the historical PE scenario, which offers more potential upside but is not a forecast.
OPRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.5x | $2.58 | -78% |
| Forward | 5.9x | $11.76 | — |
| Fair | 10x | $7.71 | -34% |
| Current | 16x | $11.76 | — |
| Expensive | 20x | $14.88 | +27% |
Historical ranges are pointers, not guarantees.
OPRT's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 5.9x next year's earnings, in its cheap range.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
OPRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for OPRT, with profitability improving.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
OPRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.00 | +170% |
| Q3 2026 | $0.74 | +2.8% |
| Q2 2026 | $0.40 | +$0.54 |
| Q1 2026 | $0.37 | +$1.43 |
| Q4 2025 | $0.53 | +$2.48 |
| Q3 2025 | $0.72 | +$3.85 |
| Q2 2025 | -$0.14 | +$2.79 |
| Q1 2025 | -$1.06 | +$1.50 |
| Q4 2024 | -$1.95 | +$2.93 |
OPRT's earnings per share have fallen from their peak: $0.74 over the past year, against $2.83 in early 2022.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over OPRT on profitability, with a higher operating margin.
OPRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $126.6M | +20% |
| Q2 2026 | $105.6M | +1% |
| Q1 2026 | $94.9M | -10% |
| Q4 2025 | $90.4M | -3.2% |
| Q3 2025 | $105.1M | +68% |
| Q2 2025 | $104.6M | +74% |
| Q1 2025 | $105.8M | +34% |
| Q4 2024 | $93.4M | +30% |
OPRT's revenue is recovering but still below its 2022 peak: $127M last quarter, up 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 27% | +14 points |
| Q2 2026 | 15% | +5.1 points |
| Q1 2026 | 3.8% | -8.7 points |
| Q4 2025 | 7.3% | +3.1 points |
| Q3 2025 | 14% | +77 points |
| Q2 2025 | 9.7% | +92 points |
| Q1 2025 | 12% | +51 points |
| Q4 2024 | 4.2% | +84 points |
OPRT's operating margin was 27% last quarter, up 14 points from the same quarter a year ago, near the top of its range since 2019.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
OPRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $118.9M | +20% |
| Q2 2026 | $109.3M | +4.6% |
| Q1 2026 | $103.7M | +2.7% |
| Q4 2025 | $108.9M | +19% |
| Q3 2025 | $99M | -8.7% |
| Q2 2025 | $104.5M | -3% |
| Q1 2025 | $101M | +18% |
| Q4 2024 | $91.4M | -14% |
OPRT has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over OPRT on shareholder dilution, with a more favorable share count trend.
OPRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.2% | +1.6M shares |
| 1 year | +5.5% | +2.7M shares |
| 3 years | +33% | +12.7M shares |
| 5 years | +67% | +20.5M shares |
| Available history | +89% | +24M shares |
OPRT has 51M diluted shares, up 5.5% from a year ago.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
OPRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.9x | Net Cash |
| Q2 2026 | 0.0x | Very low |
| Q1 2026 | 0.9x | Very low |
| Q4 2025 | 1.9x | Healthy |
| Q3 2025 | 3.0x | Elevated |
| Q2 2025 | 15.5x | High |
| Q2 2022 | 15.4x | High |
| Q1 2022 | 10.5x | High |
OPRT has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
OPRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 83.4 | Overbought |
| Stochastic | 81.4 | Overbought |
OPRT's weekly RSI is 83 (overbought) and its Stochastic is 81 (overbought).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over OPRT on valuation relative to its sector.
OPRT PE vs Financial Services Sector
| Metric | OPRT | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 22% above |
| PE % | 72 | 63 | 9 pts above |
OPRT is trading at 16x earnings, a 22% premium to the Financial Services sector's median of 13x.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
OPRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.63 | 22% above |
| 20 week MA | $8.03 | 46% above |
| 50 week MA | $6.36 | 85% above |
| 100 week MA | $6.05 | 94% above |
| 200 week MA | $5.15 | 128% above |
OPRT has the edge over MS on trend strength, trading above more of its moving averages.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.
OPRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.3 | $19.2 | -18% |
| 2021 | $19.2 | $21.2 | +10% |
| 2022 | $21.2 | $5.20 | -75% |
| 2023 | $5.20 | $3.91 | -25% |
| 2024 | $3.91 | $4.07 | +4.1% |
| 2025 | $4.07 | $5.37 | +32% |
| 2026 YTD | $5.37 | $11.8 | +119% |
OPRT has the edge over MS on returns for 2026, with the stronger performance.